Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Testing effectiveness (Phase 2)UnknownNCT01869166
What this trial is testing

Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)

Who this might be right for
Advanced EGFR-positive Solid Tumors
Chinese PLA General Hospital 60
Very early researchStudy completedNCT00140556
What this trial is testing

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerPharynx Cancer
David M. Brizel, MD 28
Post-approval studies (Phase 4)Study completedNCT01853566
What this trial is testing

Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old

Who this might be right for
Healthy
Universidade Federal do Rio de Janeiro 13
Not applicableNot Yet RecruitingNCT07113418
What this trial is testing

Role of FGF21 in Breast Cancer

Who this might be right for
Breast Cancer
Assiut University 84
Testing effectiveness (Phase 2)Ended earlyNCT02479490
What this trial is testing

PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI

Who this might be right for
Metastatic Renal Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 8
Large-scale testing (Phase 3)Study completedNCT01940497
What this trial is testing

The Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 240
Testing effectiveness (Phase 2)Looking for participantsNCT07111520
What this trial is testing

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
BioNTech SE 880
Large-scale testing (Phase 3)Ended earlyNCT04066491
What this trial is testing

Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
EMD Serono Research & Development Institute, Inc. 309
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07757230
What this trial is testing

A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Shenyang Sunshine Pharmaceutical Co., LTD. 87
Testing effectiveness (Phase 2)Looking for participantsNCT06760819
What this trial is testing

Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Solid TumorsHER2 Mutation
Bayer 111
Not applicableStudy completedNCT00059020
What this trial is testing

The Role of Gene Changes in Brain Tumor Formation and Growth

Who this might be right for
Glioma
National Institute of Neurological Disorders and Stroke (NINDS) 344
Large-scale testing (Phase 3)Study completedNCT00553358
What this trial is testing

Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 455
Testing effectiveness (Phase 2)Study completedNCT00913835
What this trial is testing

Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Eli Lilly and Company 125
Testing effectiveness (Phase 2)Looking for participantsNCT06263543
What this trial is testing

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

Who this might be right for
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+2 more
Reshma L. Mahtani, D.O. 75
Early research (Phase 1)Study completedNCT06115902
What this trial is testing

TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 153
Not applicableAvailableNCT07675057
What this trial is testing

Expanded Access for Vepugratinib (LY3866288) in Participants With Fibroblast Growth Factor Receptor 3 (FGFR3) Altered Solid Tumors

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisCarcinoma, Transitional Cell
Eli Lilly and Company
Post-approval studies (Phase 4)Not Yet RecruitingNCT07665177
What this trial is testing

Abrupt Discontinuation Versus Gradual Tapering of Propranolol in Infantile Hemangioma

Who this might be right for
Infantile Hemangioma (IH)
West China Hospital 110
Very early researchNot Yet RecruitingNCT07498595
What this trial is testing

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Who this might be right for
EGFR-TKI-resistant Non-Small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Not applicableEnrolling By InvitationNCT06814353
What this trial is testing

Intraoperatively Observed Site of Origin and Growth Pattern of Medulloblastoma

Who this might be right for
Medulloblastoma
Christian Dorfer 100
Next Page